Bivalirudin fails to prevent atrial thrombus development in heparin-induced thrombocytopaenia and thrombosis syndrome

BMJ Case Rep. 2018 Oct 14:2018:bcr2018225986. doi: 10.1136/bcr-2018-225986.

Abstract

An 81-year-old woman presented with acute decompensated heart failure due to new-onset atrial fibrillation and a flail myxomatous mitral valve which necessitated surgical mitral valve repair. No atrial thrombi were noted on transoesophageal echocardiograms performed prior to surgery and intraoperatively. Immediately postoperatively, while treated with unfractionated heparin, the patient developed thrombocytopaenia with positive platelet factor 4 antibodies and an abnormal serotonin functional platelet assay, consistent with heparin-induced thrombocytopaenia. The anticoagulation therapy was changed to the direct thrombin inhibitor bivalirudin with an improvement in the platelet count. Despite bivalirudin therapy, a left atrial layering thrombus was revealed on transoesophageal echocardiogram performed in preparation for cardioversion of the symptomatic atrial fibrillation. Anticoagulation was changed to warfarin, and the patient was discharged without thromboembolic complications neither during her hospital stay nor the 3-year outpatient follow-up.

Keywords: cardiovascular medicine; cardiovascular system; haematology (drugs and medicines); unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Antithrombins / therapeutic use*
  • Coronary Thrombosis / chemically induced*
  • Coronary Thrombosis / drug therapy
  • Echocardiography, Transesophageal
  • Female
  • Heparin / adverse effects*
  • Heparin / therapeutic use
  • Hirudins
  • Humans
  • Peptide Fragments / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / drug therapy
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Antithrombins
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • Warfarin
  • Heparin
  • bivalirudin